Skip to content

A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer

A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02135653
Enrollment
68
Registered
2014-05-12
Start date
2013-03-31
Completion date
2019-12-31
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

This study will ascertain the feasibility and effect of Eischens yoga interventions on radiation related fatigue, sexual dysfunction and urinary incontinence in stage I /II prostate cancer patients undergoing radiotherapy with photons and/or protons without prostatectomy. Subjects must be smoke free and have not taken regular yoga classes 6 months prior to enrollment. Subjects will participate in twice weekly yoga sessions for 8 weeks and complete 4 quality of life forms 5 times during study.

Detailed description

The feasibility study refers to the ability to recruit patients willing to participate in the Eischens yoga interventional arm. Those who are recruited during the feasibility study are seemlessly move to the Phase II study, and for this reason the feasibility study and Eischens yoga interventional arms are reported simply as the Eischens yoga interventional arm.

Interventions

RADIATIONRadiotherapy
OTHEREischens Yoga

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients * Prostate cancer patients undergoing active radiation therapy (external beam radiation with photons and/ or protons). Prior or concurrent androgen deprivation therapy is permitted. * Patients of age \>18 years, and all races will be included in the study. * Patients must have an ECOG Performance Score ≤ 1 * All patients must sign an informed consent form Caregivers * Subject is age \>18 years * Subject is English-speaking * Subject must sign an informed consent form

Exclusion criteria

Patients * Patients with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions per their physician orders as evaluated by ECOG Performance Status score. * Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included) * Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months). * Patients who are undergoing chemotherapy for any reason * Patients with evidence of metastatic disease Caregivers * Subjects that are unwilling or unable to provide informed consent * Subjects with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions * Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included) * Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months).

Design outcomes

Primary

MeasureTime frame
Adverse Events8 weeks

Secondary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy: Physical Well-Being Score8 weeks7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better physical well-being
Functional Assessment of Cancer Therapy: Social Well-Being Score8 weeks7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better social well-being
Functional Assessment of Cancer Therapy: Emotional Well-Being Score8 weeks6 item 5 point Likert-scale questionnaire. 0 - 30 range with larger number implies better emotional well-being
Brief Fatigue Inventory Score8 weeksA 9 item 11 point Likert-scale that rapidly assesses fatigue severity 0 - 90 range with greater numbers indicating greater levels of fatigue
International Index of Erectile Function Score8 weeks5 item and 5 point Likert-scale The scores range from 0 to 25, with scores \>21 indicating normal erectile function and scores \<12 indicating moderate to severe ED
International Prostate Symptom Score8 weeks8 item 6 point Likert-scale Scores on this scale range from 0 to 35, with a score of 8 to 19 indicating moderate urinary symptoms and 20 to 35 severe urinary symptoms
Functional Assessment of Cancer Therapy: Functional Well-Being8 weeks7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better functional well-being

Countries

United States

Participant flow

Pre-assignment details

Feasibility Phase and Phase II: Radiotherapy and Eischens Yoga have been combined because the feasibility phase's purpose was to identify and recruit patients willing to participate in the Phase II: Radiotherapy and Eischens Yoga. Those in the feasibility are seamlessly enrolled in the Phase II: Radiotherapy and Eischens Yoga.

Participants by arm

ArmCount
Feasibility/Phase II: Radiotherapy and Eischens Yoga
Radiotherapy and Eischens Yoga
22
Phase II: Radiotherapy Without Eischens Yoga
Radiotherapy without Eischens Yoga
28
Total50

Baseline characteristics

CharacteristicFeasibility/Phase II: Radiotherapy and Eischens YogaPhase II: Radiotherapy Without Eischens YogaTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
17 Participants23 Participants40 Participants
Age, Categorical
Between 18 and 65 years
5 Participants5 Participants10 Participants
Age, Continuous71.1 years
STANDARD_DEVIATION 6.7
72.8 years
STANDARD_DEVIATION 7
72.08 years
STANDARD_DEVIATION 6.84
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants28 Participants50 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants3 Participants
Race (NIH/OMB)
White
19 Participants24 Participants43 Participants
Region of Enrollment
United States
22 participants28 participants50 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
22 Participants28 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 28
other
Total, other adverse events
0 / 220 / 28
serious
Total, serious adverse events
0 / 220 / 28

Outcome results

Primary

Adverse Events

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
Feasibility/Phase II: Radiotherapy and Eischens YogaAdverse Events0 Adverse Events
Phase II: Radiotherapy Without Eischens YogaAdverse Events0 Adverse Events
Secondary

Brief Fatigue Inventory Score

A 9 item 11 point Likert-scale that rapidly assesses fatigue severity 0 - 90 range with greater numbers indicating greater levels of fatigue

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaBrief Fatigue Inventory Score12.2 score on a scaleStandard Deviation 16.3
Phase II: Radiotherapy Without Eischens YogaBrief Fatigue Inventory Score27.4 score on a scaleStandard Deviation 18.3
Secondary

Functional Assessment of Cancer Therapy: Emotional Well-Being Score

6 item 5 point Likert-scale questionnaire. 0 - 30 range with larger number implies better emotional well-being

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaFunctional Assessment of Cancer Therapy: Emotional Well-Being Score20.1 score on a scaleStandard Deviation 3.4
Phase II: Radiotherapy Without Eischens YogaFunctional Assessment of Cancer Therapy: Emotional Well-Being Score21.0 score on a scaleStandard Deviation 2.2
Secondary

Functional Assessment of Cancer Therapy: Functional Well-Being

7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better functional well-being

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaFunctional Assessment of Cancer Therapy: Functional Well-Being22.5 score on a scaleStandard Deviation 4.8
Phase II: Radiotherapy Without Eischens YogaFunctional Assessment of Cancer Therapy: Functional Well-Being21.4 score on a scaleStandard Deviation 4
Secondary

Functional Assessment of Cancer Therapy: Physical Well-Being Score

7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better physical well-being

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaFunctional Assessment of Cancer Therapy: Physical Well-Being Score24.9 score on a scaleStandard Deviation 2.3
Phase II: Radiotherapy Without Eischens YogaFunctional Assessment of Cancer Therapy: Physical Well-Being Score24.3 score on a scaleStandard Deviation 3
Secondary

Functional Assessment of Cancer Therapy: Social Well-Being Score

7 item 5 point Likert-scale questionnaire. 0 - 35 range with larger number implies better social well-being

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaFunctional Assessment of Cancer Therapy: Social Well-Being Score23.5 score on a scaleStandard Deviation 2.1
Phase II: Radiotherapy Without Eischens YogaFunctional Assessment of Cancer Therapy: Social Well-Being Score21.4 score on a scaleStandard Deviation 3.6
Secondary

International Index of Erectile Function Score

5 item and 5 point Likert-scale The scores range from 0 to 25, with scores \>21 indicating normal erectile function and scores \<12 indicating moderate to severe ED

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaInternational Index of Erectile Function Score22.5 score on a scaleStandard Deviation 4.8
Phase II: Radiotherapy Without Eischens YogaInternational Index of Erectile Function Score21.4 score on a scaleStandard Deviation 4
Secondary

International Prostate Symptom Score

8 item 6 point Likert-scale Scores on this scale range from 0 to 35, with a score of 8 to 19 indicating moderate urinary symptoms and 20 to 35 severe urinary symptoms

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Feasibility/Phase II: Radiotherapy and Eischens YogaInternational Prostate Symptom Score10.8 score on a scaleStandard Deviation 8.1
Phase II: Radiotherapy Without Eischens YogaInternational Prostate Symptom Score15 score on a scaleStandard Deviation 6.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026